CAMLIN FINE SCIENCES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 99.85 INR | 0.00% |
|
-0.89% | -26.50% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 16.47B 198M | Sales 2025 * | 21.79B 262M | Capitalization | 16.72B 201M |
|---|---|---|---|---|---|
| Net income 2024 * | -95M -1.14M | Net income 2025 * | 984M 11.82M | EV / Sales 2024 * | 1.02 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.77 x |
| P/E ratio 2024 * |
-166
x | P/E ratio 2025 * |
15.8
x | Employees | 627 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 55.2% |
More Fundamentals
* Assessed data
More news
Latest transcript on Camlin Fine Sciences Limited
| 1 week | -0.89% | ||
| Current month | -5.99% | ||
| 1 month | -7.69% | ||
| 3 months | -20.97% | ||
| 6 months | -23.75% | ||
| Current year | -26.50% |
1 week
98.60
102.20
1 month
97.10114.00
Current year
88.45139.50
1 year
88.45186.25
3 years
88.45230.80
5 years
33.40230.80
10 years
29.00230.80
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 04/14/04 | |
| Chief Executive Officer | 61 | 11/07/11 | |
Santosh L. Parab
DFI | Director of Finance/CFO | - | 10/17/10 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Joseph D'Souza
BRD | Director/Board Member | 64 | 29/20/29 |
| Chief Executive Officer | 61 | 11/07/11 | |
Sutapa Banerjee
BRD | Director/Board Member | 59 | 07/20/07 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 112 M€ | +5.72% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/24/18 | 99.85 | +0.05% | 18,620 |
| 17/24/17 | 99.8 | +0.60% | 15,614 |
| 16/24/16 | 99.2 | -0.55% | 29,824 |
| 15/24/15 | 99.75 | -0.99% | 21,828 |
| 14/24/14 | 100.8 | +2.18% | 23,689 |
Delayed Quote Bombay S.E., May 18, 2024 at 12:30 pm IST
More quotes
Camlin Fine Sciences Limited is an India-based company, which is engaged in research, development, manufacturing and marketing of specialty chemicals, ingredients, and additive blends. The Company is a provider of diverse advanced antioxidants and shelf-life extensions, aroma ingredients, performance chemical products and related solutions for food, animal nutrition, pet food, pharmaceutical and petrochemical industries globally. Its products include TBHQ, Catechol, BHA, 4-Tertiary Butyl Catechol, Xtendra, Butylated Hydroxy Toluene, Guaiacol, Para DiMethoxy Benzene, NaSure, MEHQ, Ascorbyl Palmitate, and HQEE. The Company manufactures specialty chemicals that can be categorized into shelf-life solutions, performance chemicals, aroma ingredients and health and wellness. Its products are used in varied industries, such as human food, animal feed, pet food, agrochemicals, petrochemicals, pharmaceuticals, nutraceuticals, flavors and fragrances and health care.
Sector
Specialty Chemicals
Calendar
20/05/2024
- Q4 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
99.85
INR
Average target price
150
INR
Spread / Average Target
+50.23%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -26.50% | 201M | |
| +2.92% | 49.79B | |
| +19.98% | 42.5B | |
| +22.29% | 26.45B | |
| +12.04% | 19.66B | |
| +1.15% | 17.18B | |
| -24.51% | 15.82B | |
| +3.37% | 15.56B | |
| -11.43% | 15.41B | |
| -20.64% | 13.67B |
- Stock Market
- Equities
- CAMLINFINE Stock